Total Polyphenol Intake Is Inversely Associated with a Pro/Anti-Inflammatory Biomarker Ratio in European Adolescents of the HELENA Study.


Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 15 10 2019
revised: 03 01 2020
accepted: 25 02 2020
pubmed: 30 3 2020
medline: 20 11 2020
entrez: 30 3 2020
Statut: ppublish

Résumé

Although high dietary polyphenol intake is negatively associated with risk of certain inflammation-associated chronic diseases, the underlying mechanisms are not fully understood and few studies have explored this in adolescents. This study aimed to evaluate the association between intakes of total polyphenols, polyphenol classes, and the 10 most commonly consumed individual polyphenols with inflammatory biomarkers in the blood of European adolescents. In the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) Study, 526 adolescents (54% girls; 12.5-17.5 y) had data on inflammatory biomarkers and polyphenol intake from 2 nonconsecutive 24-h recalls via matching with the Phenol-Explorer database. Inflammatory biomarkers in serum were IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, transforming growth factor β1 (TGF-β1), TNF-α, IFN-γ, soluble vascular adhesion molecule 1 (sVCAM-1), soluble intercellular adhesion molecule 1 (sICAM-1), soluble E-selectin (sE-selectin), white blood cells, lymphocytes, T cells, and C-reactive protein. Multilevel linear models were used to test associations of polyphenol intake with a pro/anti-inflammatory biomarker ratio [(zTNF-α + zIL-6 + zIL-1)/3/zIL-10] as well as with separate inflammatory biomarkers, adjusted for sociodemographic variables, diet inflammation index, BMI z score, and serum triglycerides. The pro/anti-inflammatory biomarker ratio was linearly inversely associated with the intake of total polyphenols (β = -0.11, P = 0.040). When other inflammation biomarkers were considered, the serum IL-10 concentration was inversely associated with total polyphenol (β = -0.12, P = 0.017) and flavonoid (β = -0.12, P = 0.013) intakes, findings that were inconsistent with the biomarker ratio results. However, the anti-inflammatory capacity of polyphenols was confirmed by positive associations of IL-4 with phenolic acid (β = 0.09 P = 0.049) and stilbene (β = 0.13, P = 0.019) intakes and the negative association of IL-1, IL-2, and IFN-γ with lignan intake (β = -0.10, P = 0.034; β = -0.09, P = 0.049; β = -0.11, P = 0.023). The negative relation with the overall pro/anti-inflammatory biomarker ratio suggests a potential anti-inflammatory role of high polyphenol intakes among European adolescents. Nevertheless, associations are dependent on polyphenol type and the inflammatory biomarker measured.

Sections du résumé

BACKGROUND
Although high dietary polyphenol intake is negatively associated with risk of certain inflammation-associated chronic diseases, the underlying mechanisms are not fully understood and few studies have explored this in adolescents.
OBJECTIVE
This study aimed to evaluate the association between intakes of total polyphenols, polyphenol classes, and the 10 most commonly consumed individual polyphenols with inflammatory biomarkers in the blood of European adolescents.
METHODS
In the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) Study, 526 adolescents (54% girls; 12.5-17.5 y) had data on inflammatory biomarkers and polyphenol intake from 2 nonconsecutive 24-h recalls via matching with the Phenol-Explorer database. Inflammatory biomarkers in serum were IL-1, IL-2, IL-4, IL-5, IL-6, IL-10, transforming growth factor β1 (TGF-β1), TNF-α, IFN-γ, soluble vascular adhesion molecule 1 (sVCAM-1), soluble intercellular adhesion molecule 1 (sICAM-1), soluble E-selectin (sE-selectin), white blood cells, lymphocytes, T cells, and C-reactive protein. Multilevel linear models were used to test associations of polyphenol intake with a pro/anti-inflammatory biomarker ratio [(zTNF-α + zIL-6 + zIL-1)/3/zIL-10] as well as with separate inflammatory biomarkers, adjusted for sociodemographic variables, diet inflammation index, BMI z score, and serum triglycerides.
RESULTS
The pro/anti-inflammatory biomarker ratio was linearly inversely associated with the intake of total polyphenols (β = -0.11, P = 0.040). When other inflammation biomarkers were considered, the serum IL-10 concentration was inversely associated with total polyphenol (β = -0.12, P = 0.017) and flavonoid (β = -0.12, P = 0.013) intakes, findings that were inconsistent with the biomarker ratio results. However, the anti-inflammatory capacity of polyphenols was confirmed by positive associations of IL-4 with phenolic acid (β = 0.09 P = 0.049) and stilbene (β = 0.13, P = 0.019) intakes and the negative association of IL-1, IL-2, and IFN-γ with lignan intake (β = -0.10, P = 0.034; β = -0.09, P = 0.049; β = -0.11, P = 0.023).
CONCLUSIONS
The negative relation with the overall pro/anti-inflammatory biomarker ratio suggests a potential anti-inflammatory role of high polyphenol intakes among European adolescents. Nevertheless, associations are dependent on polyphenol type and the inflammatory biomarker measured.

Identifiants

pubmed: 32221603
pii: S0022-3166(22)02198-8
doi: 10.1093/jn/nxaa064
doi:

Substances chimiques

Biomarkers 0
Inflammation Mediators 0
Polyphenols 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1618

Informations de copyright

Copyright © The Author(s) 2020.

Auteurs

Ratih Wirapuspita Wisnuwardani (RW)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Department of Public Health Nutrition, Faculty of Public Health, Mulawarman University, Samarinda, Indonesia.

Stefaan De Henauw (S)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Marika Ferrari (M)

CREA Research Center for Food and Nutrition, Rome, Italy.

Maria Forsner (M)

Department of Nursing, Umeå University, Umeå, Sweden.
School of Education, Health, and Social Sciences, Dalarna University, Falun, Sweden.

Frédéric Gottrand (F)

CHU Lille, Inserm U995, University of Lille, Lille, France.

Inge Huybrechts (I)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
International Agency for Research on Cancer, World Health Organization, Lyon, France.

Antonios G Kafatos (AG)

Clinic of Nutrition and Disease Prevention, School of Medicine, University of Crete, Crete, Greece.

Mathilde Kersting (M)

Research Department of Child Nutrition, Pediatric University Clinic, Ruhr-University Bochum, Bochum, Germany.

Viktoria Knaze (V)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Yannis Manios (Y)

Department of Nutrition and Dietetics, Harokopio University, Athens, Greece.

Ascensión Marcos (A)

Immunonutrition Research Group, Department of Metabolism and Nutrition, Institute of Food Science, Technology, and Nutrition, Madrid, Spain.

Dénes Molnár (D)

Departments of Pediatrics, Medical School, University of Pécs, Pécs, Hungary.

Joseph A Rothwell (JA)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Azahara Iris Rupérez (AI)

GENUD (Growth, Exercise, Nutrition, and Development) Research Group, Faculty of Health Science, University of Zaragoza, Edificio del SAI, C/Pedro Cerbuna s/n, Zaragoza, Spain.

Augustin Scalbert (A)

International Agency for Research on Cancer, World Health Organization, Lyon, France.

Kurt Widhalm (K)

Department of Pediatric, Division of Clinical Nutrition, Medical University of Vienna, Vienna, Austria.

Luis A Moreno (LA)

GENUD (Growth, Exercise, Nutrition, and Development) Research Group, Faculty of Health Science, University of Zaragoza, Edificio del SAI, C/Pedro Cerbuna s/n, Zaragoza, Spain.

Nathalie Michels (N)

Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH